1-(2,6-DIMETHYLPYRIDIN-4-YL)ETHANONE, 95.0%, 5g

cis-Epoxysuccinic Acid>97.0%(GC)(T)5g

Zirconyl chloride octahydrate, min. 99.5%, pa, ACS, 50 g, plastic packaging.

4-(2,4-dichlorophenyl)-3H,4H,5H,6H,7H-imidazo[4,5-c]pyridine-6-carboxylic acid, 95.0%, 1g

3-aminothieno[2,3-b]pyridine-2-carboxylic acid, 95.0%, 5g

6-chloro-3-(3,4-dimethoxyphenyl)[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg

5-methyl-2-[(methylsulfanyl)methyl]-4-oxo-1H,4H-thieno[2,3-d]pyrimidine-6-carboxylic acid, 95%, 250mg

ETHYL 1-ISOPROPYL-4,5-DIOXOPYRROLIDINE-3-CARBOXYLATE, 95.0%, 1g

6-chloro-4-fluoro-1,3-benzothiazol-2-amine hydrochloride, 95.0%, 10g

(R)-1-(4-Methylphenyl)ethylamine hydrochloride, 95.0%, 250mg

(2-methoxybenzyl)propylamine, 95.0%, 1g

anti-6-His-tag mouse monoclonal, 6His, 25 µg

N-(3-fluorobenzyl)formamide, 95.0%, 1g